Ceepee Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.00 Cr
- Revenue Growth 101.42%
- Profit Growth 6546.94%
- Ebitda 237.11%
- Net Worth 21.69%
- Total Assets 4025.45%
About Ceepee Pharma
Ceepee Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 November 2010 and has a history of 14 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹20.00 Cr.
Chaman Pansari and Rashi Choudhary serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH2010PTC209695
- Company No.
209695
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2010
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ceepee Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chaman Pansari  | Director | 01-Nov-2010 | Current |
| Rashi Choudhary | Director | 01-Nov-2010 | Current |
Financial Performance of Ceepee Pharma.
Ceepee Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 101.42% increase. The company also saw a substantial improvement in profitability, with a 6546.94% increase in profit. The company's net worth Soared by an impressive increase of 21.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ceepee Pharma?
In 2021, Ceepee Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elmack Engg Services Private LimitedChaman Pansari is a mutual person
Pv Lumens LlpChaman Pansari is a mutual person
Pv Lumens India Private LimitedChaman Pansari is a mutual person
Sanwaria Texpro Private LimitedChaman Pansari and Rashi Choudhary are mutual person
- Ceekay Healthcare Private Limited
Chaman Pansari is a mutual person
Charges (Loans)
₹200.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Aug 2022 | Hdfc Bank Limited | ₹20.00 Cr | Open |
How Many Employees Work at Ceepee Pharma?
Unlock and access historical data on people associated with Ceepee Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ceepee Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ceepee Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
